- Home
- GRI vs AUUD Comparison
GRI vs AUUD Comparison
Compare GRI & AUUD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRI
- AUUD
- Stock Information
- Founded
- GRI 2018
- AUUD 2012
- Country
- GRI United States
- AUUD United States
- Employees
- GRI N/A
- AUUD N/A
- Industry
- GRI Biotechnology: Pharmaceutical Preparations
- AUUD Computer Software: Prepackaged Software
- Sector
- GRI Health Care
- AUUD Technology
- Exchange
- GRI Nasdaq
- AUUD Nasdaq
- Market Cap
- GRI 3.2M
- AUUD 2.9M
- IPO Year
- GRI N/A
- AUUD 2021
- Fundamental
- Price
- GRI $1.35
- AUUD $4.56
- Analyst Decision
- GRI Strong Buy
- AUUD
- Analyst Count
- GRI 2
- AUUD 0
- Target Price
- GRI $22.00
- AUUD N/A
- AVG Volume (30 Days)
- GRI 110.6K
- AUUD 70.8K
- Earning Date
- GRI 08-13-2025
- AUUD 08-06-2025
- Dividend Yield
- GRI N/A
- AUUD N/A
- EPS Growth
- GRI N/A
- AUUD N/A
- EPS
- GRI N/A
- AUUD N/A
- Revenue
- GRI N/A
- AUUD N/A
- Revenue This Year
- GRI N/A
- AUUD N/A
- Revenue Next Year
- GRI N/A
- AUUD N/A
- P/E Ratio
- GRI N/A
- AUUD N/A
- Revenue Growth
- GRI N/A
- AUUD N/A
- 52 Week Low
- GRI $1.10
- AUUD $2.88
- 52 Week High
- GRI $43.69
- AUUD $31.62
- Technical
- Relative Strength Index (RSI)
- GRI 41.49
- AUUD 48.50
- Support Level
- GRI $1.20
- AUUD $4.15
- Resistance Level
- GRI $1.35
- AUUD $7.29
- Average True Range (ATR)
- GRI 0.10
- AUUD 0.61
- MACD
- GRI 0.02
- AUUD 0.01
- Stochastic Oscillator
- GRI 37.60
- AUUD 14.15
About GRI GRI Bio Inc.
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.
About AUUD Auddia Inc.
Auddia Inc is a technology company that is engaged in radio broadcasts and streaming audio content digitally. Its products includes Auddia App which is a subscription-based commercial-free AM/FM software application, and Vodacast an interactive podcasting platform and application. The company generates revenue through subscription fees from customers accessing the company's cloud-based computing services and advertisement services.